Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands

被引:0
|
作者
Lomonte, C [1 ]
Cazzato, F [1 ]
Casucci, F [1 ]
Chimienti, D [1 ]
Bruno, A [1 ]
Cocola, S [1 ]
Verrelli, EA [1 ]
Basile, C [1 ]
机构
[1] Miulli Gen Hosp, Div Nephrol, Bari, Italy
关键词
female gender; hemodialysis; hyperparathyroidism; nodular hyperplasia; parathyroidectomy;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: An association between female gender and more aggressive patterns of secondary hyper-parathyroidisin (sHPTH) has been suggested: an increased incidence of refractory sHPTH seems evident in females; therefore, necessitating parathyroidectomy (PTx). Methods: This study aimed to verify the existence of such an association and secondly to evaluate the impact of female gender on parathyroid gland histology. Therefore, a retrospective study was conducted on 67 patients who underwent first PTx (either total or subtotal) in our hospital from 1999-2003. Out of these patients, we selected 55 (28 males, 27 females, mean age 50.8 +/- 14.7 SD yrs, dialysis duration 109.2 +/- 62.4 months) in whom all four parathyroid glands were identified and removed. Serum levels of immunoreactive intact parathyroid hormone (iPTH), alkaline phosphatase, calcium and phosphate were determined at the PTx time point. The same pathologist performed the histological studies of the parathyroid glands on seven serial sections of the glands. Gland hyperplasia was classified as (1) exclusively diffuse (EDH) when only diffuse hyperplasia was found in the four glands; (2) exclusively nodular (ENH) when only nodular hyperplasia was found in the four glands; (3) diffuse/nodular (D/NH), in which the four glands showed varying degrees of evolution towards both nodular and diffuse hyperplasia. Results: EDH was found in 13 patients with a prevalence of males (11/13; 84.6%); ENH was found in 23 patients with a prevalence of females (15/23; 65.2%); D/NH was found in 19 patients with a similar prevalence between females and males (10 females and 9 males). The difference in the male/female prevalence among the three groups was statistically significant (chi(2) test, p=0.015). Serum calcium was significantly higher in the ENH group (one-way analysis of variance, p=0.009). No difference was found among the three groups as far as age, dialysis duration, serum levels of iPTH, alkaline phosphatase and phosphate were concerned. Conclusions: Female gender is associated with more aggressive histological sHPTH patterns; this association seems to suggest that female gender predisposes to monoclonal proliferation of parathyroid glands in chronic uremia.
引用
收藏
页码:92 / 95
页数:4
相关论文
共 50 条
  • [21] Relationship Between the Weight of Parathyroid Glands and Their Secretion of Parathyroid Hormone in Hemodialysis Patients With Secondary Hyperparathyroidism
    Kakuta, Takatoshi
    Tanaka, Reika
    Kanai, Genta
    Miyamoto, Yoshiyasu
    Inagaki, Miho
    Suzuki, Hajime
    Fukagawa, Masafumi
    Saito, Akira
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (05) : 385 - 390
  • [22] Association of Nodular Hyperplasia With Resistance to Cinacalcet Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients
    Hirai, Takayuki
    Nakashima, Ayumu
    Takasugi, Norihisa
    Yorioka, Noriaki
    THERAPEUTIC APHERESIS AND DIALYSIS, 2010, 14 (06) : 577 - 582
  • [23] Large parathyroid tumors have an increased risk of atypia and carcinoma
    O'Neal, Patrick
    Mowschenson, Peter
    Connolly, James
    Hasselgren, Per-Olof
    AMERICAN JOURNAL OF SURGERY, 2011, 202 (02): : 146 - 150
  • [24] Comparison of histological findings and parathyroid scintigraphy in hemodialysis patients with secondary hyperparathyroid glands
    Nishida, H
    Ishibashi, M
    Hiromatsu, Y
    Kaida, H
    Baba, K
    Miyake, I
    Ikedo, H
    Kato, S
    Fukami, K
    Iida, S
    Okuda, S
    ENDOCRINE JOURNAL, 2005, 52 (02) : 223 - 228
  • [25] Cinacalcet Upregulates Calcium-Sensing Receptors of Parathyroid Glands in Hemodialysis Patients
    Sumida, Keiichi
    Nakamura, Michio
    Ubara, Yoshifumi
    Marui, Yuji
    Tanaka, Kiho
    Takaichi, Kenmei
    Tomikawa, Shinji
    Inoshita, Naoko
    Ohashi, Kenichi
    AMERICAN JOURNAL OF NEPHROLOGY, 2013, 37 (05) : 405 - 412
  • [26] Up-regulation of the gene encoding protein kinase A type Iα regulatory subunit in nodular hyperplasia of parathyroid glands in patients with chronic renal failure
    Hibi, Y
    Kambe, F
    Tominaga, Y
    Mizuno, Y
    Kobayashi, H
    Iwase, K
    Imai, T
    Seo, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02): : 563 - 568
  • [27] TOTAL PARATHYROIDECTOMY - PARATHYROID-HORMONE LEVELS AND SUPERNUMERARY GLANDS IN HEMODIALYSIS-PATIENTS
    MEAKINS, JL
    MILNE, CA
    HOLLOMBY, DJ
    GOLTZMAN, D
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1984, 7 (01): : 21 - 25
  • [28] HISTOLOGY AMD IMMUNOCHEMISTRY OF PARATHYROID GLANDS IN HEMODIALYSIS PATIENTS REFRACTORY TO CONVENTIONAL OR CINCALCET THERAPY
    Vulpio, Carlo
    Bossola, Maurizio
    Stigliano, Egidio
    Fadda, Guido
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 506 - 507
  • [29] Rhodesian Ridgebacks have an increased risk to develop benign prostatic hyperplasia
    Beining, Franziska Werhahn
    Urhausen, Carola
    Wolf, Karola
    Schmicke, Marion
    Rohn, Karl
    Schuler, Gerhard
    Guenzel-Apel, Anne-Rose
    REPRODUCTION IN DOMESTIC ANIMALS, 2020, 55 (03) : 283 - 292
  • [30] Fracture Risk in Patients on Hemodialysis: the Lower the Parathyroid Hormone the Better?
    Jadoul, Michel Y.
    Labriola, Laura
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (10): : 2854 - 2856